THX Pharma Société Anonyme

€3.20As of Sun 8 Nov 2026, 12:00 UTC
EPA:ALTHXHealthcare
Country France
PE (Fwd) •••
TSR 9Y CAGR (15.80%)
Div yield —
ROE (373.08%)
Biotechnology
Beta (5Y) 1.47
PE TTM —
TSR TTM 65.80%
Mkt cap €46.54M
ROIC (69.45%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€3.49
9.10%
(36.16%)
Hold 2|12|3|11|0
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.07
0.07
0.07
0.07
6.51%
10.26%
13.78%
7.20%
Revenue€M
2.550
2.537
2.668
2.668
5.93%
8.02%
8.82%
6.53%
Peers (US$52.26M)
Cap (US$)
PE
73.69M
—
61.82M
—
40.99M
—
Capital
TTM
5Y
10Y
Leveragex
0.264
(0.123)
(0.124)
EBIT/Intx
0.702
0.366
0.390
Own earn%
85.64
43.78
42.06
Sh yield%
33.53
28.33
31.02
Owners
Insiders/Inst%
1.23
45.37
Short interest%
1.63
SBC / revenue%
5.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
23–27
$1 testx
—
Incr. ROIC%
4